Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arcus Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RCUS
New York
8731
https://arcusbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arcus Biosciences Inc
Arcus Biosciences Announces New Employment Inducement Grants
- Mar 26th, 2024 8:35 pm
Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)
- Mar 20th, 2024 11:00 pm
Insider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS)
- Feb 29th, 2024 8:14 am
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
- Feb 28th, 2024 9:05 pm
Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript
- Feb 22nd, 2024 4:10 pm
Wall Street Analysts Think Arcus Biosciences, Inc. (RCUS) Could Surge 151.61%: Read This Before Placing a Bet
- Feb 22nd, 2024 2:55 pm
Q4 2023 Arcus Biosciences Inc Earnings Call
- Feb 22nd, 2024 12:16 pm
Arcus Biosciences Inc (RCUS) Reports Fourth-Quarter and Full-Year 2023 Financial Results
- Feb 21st, 2024 9:37 pm
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
- Feb 21st, 2024 9:05 pm
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates
- Feb 7th, 2024 10:00 pm
Gilead and Arcus Announce Amended Collaboration and Equity Investment
- Jan 29th, 2024 10:00 pm
Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer
- Jan 16th, 2024 10:00 pm
We Think Arcus Biosciences (NYSE:RCUS) Needs To Drive Business Growth Carefully
- Dec 9th, 2023 12:24 pm
Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data
- Dec 7th, 2023 2:25 pm
Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study
- Dec 5th, 2023 6:51 pm
Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma
- Dec 4th, 2023 1:00 pm
Arcus Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference
- Nov 14th, 2023 9:00 pm
Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Just Trimmed Their Revenue Forecasts By 17%
- Nov 12th, 2023 12:03 pm
Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2023 Earnings Call Transcript
- Nov 8th, 2023 9:05 pm
Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update
- Nov 7th, 2023 9:01 pm
Scroll